Department of Pharmacology, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan.
Life Sci. 2011 Jun 20;88(25-26):1127-35. doi: 10.1016/j.lfs.2011.04.003. Epub 2011 Apr 30.
Neutrophils have been found increasingly in the lungs of patients with severe asthma; however, it is unclear whether the neutrophils contribute to the induction of the airway obstruction. We determined using a murine model whether neutrophils are involved in the late asthmatic response (LAR), and analyzed mechanisms underlying the antigen-induced airway neutrophilia.
BALB/c mice sensitized by ovalbumin (OVA)+Al(OH)(3) were challenged 4 times by intratracheal administration of OVA. Airway mechanics were measured as specific airway resistance.
Induction of the LAR after the 4th challenge coincided with airway neutrophilia. In contrast, eosinophil infiltration was established prior to the 4th challenge. A treatment with an anti-Gr-1 monoclonal antibody (mAb) before the 4th challenge selectively suppressed increases in the neutrophil number and myeloperoxidase (MPO) level in bronchoalveolar lavage fluid (BALF), and attenuated the magnitude of LAR by 60-70%. Selective suppression of eosinophilia by anti-IL-5 mAb had little effect on the LAR. The increases in neutrophil number and MPO level were partially inhibited by an anti-CD4 mAb treatment. The CD4(+) cell depletion also significantly inhibited increases in neutrophil chemoattractants, IL-17A, keratinocyte-derived chemokine (KC) and macrophage inflammatory protein (MIP)-2 in BALF. However, blockade of FcγRII/III failed to suppress the neutrophilia.
These data suggest that neutrophils are key inducers of the LAR, and that the antigen-induced neutrophilia is partially dependent on activated CD4(+) cells that are involved in the production of IL-17A, KC and MIP-2.
越来越多的研究发现中性粒细胞存在于严重哮喘患者的肺部;然而,中性粒细胞是否导致气道阻塞尚不清楚。我们通过建立一个鼠模型来确定中性粒细胞是否参与晚期哮喘反应(LAR),并分析导致抗原诱导气道中性粒细胞增多的机制。
卵清蛋白(OVA)+氢氧化铝(Al(OH)(3))致敏的 BALB/c 小鼠通过气管内给予 OVA 进行 4 次攻击。气道力学作为气道阻力来测量。
第 4 次攻击后 LAR 的诱导与气道中性粒细胞增多同时发生。相比之下,嗜酸性粒细胞浸润在第 4 次攻击之前已经建立。在第 4 次攻击之前用抗 Gr-1 单克隆抗体(mAb)治疗可选择性地抑制支气管肺泡灌洗液(BALF)中性粒细胞数量和髓过氧化物酶(MPO)水平的增加,并使 LAR 的幅度降低 60-70%。抗 IL-5 mAb 选择性抑制嗜酸性粒细胞增多对 LAR 几乎没有影响。用抗 CD4 mAb 治疗部分抑制中性粒细胞数量和 MPO 水平的增加。CD4(+)细胞耗竭也显著抑制了 BALF 中中性粒细胞趋化因子 IL-17A、角质细胞衍生的趋化因子(KC)和巨噬细胞炎症蛋白(MIP)-2 的增加。然而,FcγRII/III 的阻断不能抑制中性粒细胞增多。
这些数据表明中性粒细胞是 LAR 的关键诱导剂,并且抗原诱导的中性粒细胞增多部分依赖于活化的 CD4(+)细胞,这些细胞参与了 IL-17A、KC 和 MIP-2 的产生。